Literature DB >> 7564727

Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old.

K Ritchie1, D Kildea.   

Abstract

The observation of an exponential increase in senile dementia prevalence with age has led to the conclusion that this disease may be inevitable in those who live long enough. The alternative view is that at very high ages the prevalence rate levels off. Studies conducted to date have not included sufficient numbers of very old people to resolve this difference of opinion. The question is important both to our understanding of the biological mechanisms involved and for public health planning. We have carried out a meta-analysis of nine epidemiological studies of senile dementia that used DSM III diagnostic criteria and that included samples of elderly people over age 80. The resulting curve was best described as a flattened S curve that fitted a modified logistic function rather than an exponential pattern. The rate of increase in senile dementia prevalence was found to fall in the age range 80-84, and at around the age of 95 prevalence was seen to level off to about 40%. It seems that senile dementia is better conceptualised as an "age-related" (ie, occurring within a specific age range) rather than as an "ageing-related" disorder (that is, caused by the ageing process itself). Very elderly survivors may be at diminishing risk of dementia and this has implications for public health policy.

Entities:  

Mesh:

Year:  1995        PMID: 7564727     DOI: 10.1016/s0140-6736(95)91556-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  53 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

Review 2.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 3.  The epidemic of Alzheimer's disease. How can we manage the costs?

Authors:  N Johnson; T Davis; N Bosanquet
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

Review 4.  [Whats new on dementia?].

Authors:  S Riu-Subirana; J L Rodríguez-Cubas
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

5.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.

Authors:  Susan De Santi; Elizabeth Pirraglia; William Barr; James Babb; Schantel Williams; Kimberley Rogers; Lidia Glodzik; Miroslaw Brys; Lisa Mosconi; Barry Reisberg; Steven Ferris; Mony J de Leon
Journal:  Neuropsychology       Date:  2008-07       Impact factor: 3.295

Review 6.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

Review 7.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

8.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

9.  Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.

Authors:  Pavel Katsel; Weilun Tan; Vahram Haroutunian
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.